CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Leerink Partners Adjusts Quest Diagnostics Price Target to $265 From $254

Positive
AI Analysis

Summary

Leerink Partners raised its price target on Quest Diagnostics to $265 from $254.

Outcome Details

Leerink Partners raised price target from $254 to $265

Importance:3/10
Sentiment:
0.40
analyst ratingprice targetdiagnostics
Related Companies

Read the original article

Published by yahoo_finance on October 8, 2026 11:46 AM

Read Original